Copyright
©The Author(s) 2022.
World J Gastroenterol. Nov 21, 2022; 28(43): 6099-6108
Published online Nov 21, 2022. doi: 10.3748/wjg.v28.i43.6099
Published online Nov 21, 2022. doi: 10.3748/wjg.v28.i43.6099
Category | Effects | Ref. | |
Lifestyle measures | Mediterranean diet | Inhibition of inflammation and oxidative stress that occur in OSAHS and improvement of upper-airway neuromuscular control and muscle force-generating capacity | [51] |
Dietary behavior change, moderate-intensity aerobic exercise, sleep hygiene, and tobacco and alcohol avoidance | Increases in adherence to the Mediterranean diet | [52] | |
Reduced AHI and oxygen desaturation index | |||
Increased sleep quality | |||
Decease of body weight, fat mass, visceral adipose tissue, and neck, chest, and waist circumferences | |||
Aerobic exercise training | Reduced body weight improved blood circulation, better sleep quality and less daytime sleepiness | [56-58] | |
Medications | Phentermine plus extended-release topiramate | Significant improvements in overnight oxygen saturation and reduction in blood pressure | [42] |
Liraglutide and semaglutide | Histological resolution of NASH and improved metabolic control | [43-48] | |
Decreased AHI, body weight, SBP and HbA1c | |||
MBS | VSG or other MBS | Reduced AHI | [62-64] |
VSG | 100% remission rate in patients with OSAHS who also underwent hiatal hernia repair | [65] | |
MBS | Improved sleep apnea and nocturnal hypoxia, as well as liver steatosis and fibrosis | [66] |
- Citation: Sheng W, Ji G, Zhang L. Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome. World J Gastroenterol 2022; 28(43): 6099-6108
- URL: https://www.wjgnet.com/1007-9327/full/v28/i43/6099.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i43.6099